You are here

Novo Nordisk

Novo Nordisk Quietly Becoming Big Player In Obesity Space

Seeking Alpha

Fri, 04/10/15 - 09:27 am

Novo Nordisk's Tresiba news a black cloud for Sanofi's new CEO

Fierce Pharma

Fri, 03/27/15 - 09:44 pm

Olivier Brandicourt

Novo Nordisk filing move brings Tresiba closer to U.S. market

Yahoo/Reuters

Thu, 03/26/15 - 09:28 pm

Bristol-Myers buys rights to Novo Nordisk immune system project

Yahoo/Reuters

Tue, 03/24/15 - 10:30 am

Bristol-Myers Squibb

autoimmune disease

Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better"

Forbes

Fri, 03/20/15 - 08:20 am

clinical trials

How Novo Nordisk plans to keep its eyes on the diabetes prize

BioPharma Dive

Wed, 03/18/15 - 11:38 am

Novo Nordisk Readies For Saxenda Launch - Investors Need To Keep Expectations Realistic

Seeking Alpha

Tue, 03/10/15 - 08:28 am

FDA OKs Sanofi's Toujeo. Will a diabetes drug price war follow?

Fierce Biotech

Thu, 02/26/15 - 10:00 am

Novo-Nordisk's Oral GLP-1 Diabetes Treatment: An Update

Seeking Alpha

Sat, 02/21/15 - 09:38 am

Patient groups still think ViiV is tops, with Novo and AbbVie close behind

Fierce Pharma Marketing

Wed, 02/11/15 - 09:47 am

Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono

Fierce Biotech

Tue, 02/10/15 - 10:40 am

Ono Pharmaceutical

Sanofi undertakes major sales reorg of US diabetes business

BioPharma Dive

Tue, 02/10/15 - 10:39 am

Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving

WSJ Pharmalot

Tue, 02/10/15 - 08:41 am

Bristol-Myers Squibb

Gilead Sciences

Novo Nordisk joins pharma's IPO clique with plans for tech subsidiary spinoff

Fierce Pharma

Mon, 02/9/15 - 10:35 am

Forget Pfizer! This Big Pharmaceutical Stock is Better

Motley Fool

Sun, 02/8/15 - 10:03 am

Moody's: Patent-cliff challenges will continue to dog big pharma

BioPharma Dive

Wed, 02/4/15 - 01:43 pm

Bristol-Myers Squibb

Victoza powers Novo's strong year; CEO projects growth for 2015

Fierce Pharma

Fri, 01/30/15 - 11:15 am

Novo Nordisk puts 500 Saxenda reps on U.S. streets, aiming for $1B in weight-loss sales

Fierce Pharma

Tue, 01/27/15 - 08:41 am

Novo Nordisk stock rises on $2 billion buyback

Marketwatch

Mon, 01/26/15 - 08:10 am

Novo Nordisk Plans to Move Forward With Investments in Russia

Bloomberg

Fri, 01/23/15 - 08:32 am

Pages